NCT06643325 Gastric Emptying Time in Traumatic Injuries
| NCT ID | NCT06643325 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kantonsspital Winterthur KSW |
| Condition | Anesthesia |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-02-01 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators plan to do serial sonographic examinations of the gastric antrum (quantity, quality) to estimate the gastric emptying time and dependant factors after traumatic injurys.
Eligibility Criteria
Inclusion Criteria: * relevant traumatic injury Exclusion Criteria: * life-threatening traumatic injury (immediate treatment is necessary) * Underage * Known pregnancy
Frequently Asked Questions
Who can join the NCT06643325 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06643325 currently recruiting?
Yes, NCT06643325 is actively recruiting participants. Visit ClinicalTrials.gov or contact Kantonsspital Winterthur KSW to inquire about joining.
Where is the NCT06643325 trial being conducted?
This trial is being conducted at Winterthur, Switzerland.
Who is sponsoring the NCT06643325 clinical trial?
NCT06643325 is sponsored by Kantonsspital Winterthur KSW. The trial plans to enroll 200 participants.